Changyao Group(SZ:300391) Zheng Quan Zhi Xing·2025-07-14 16:24Core Viewpoint - The announcement details the completion of the board of directors' re-election and the appointment of senior management and securities representatives at Changjiang Pharmaceutical Holdings Co., Ltd. [1] Group 1: Board of Directors - The sixth board of directors consists of 9 members, including 3 independent directors, with a term of three years starting from the date of election [1] - The board members meet the qualifications set by the Company Law of the People's Republic of China and other relevant regulations, with no history of penalties from the China Securities Regulatory Commission [1][2] - The independent directors have obtained the necessary qualifications, with one member committed to completing the required training [1] Group 2: Specialized Committees - The sixth board has established four specialized committees: Strategy Committee, Nomination Committee, Audit Committee, and Compensation and Assessment Committee [2] - The Audit Committee is chaired by Wei Jian, with members Du Shiming and Gao Yinghui [2] - The Nomination Committee is chaired by Sun Zhaohong, with members Du Shiming and Gu Ziguang [2] Group 3: Senior Management Appointments - The board has appointed senior management and securities representatives for a term of three years, starting from the first meeting of the sixth board [4] - The board secretary and securities representative have obtained the necessary qualifications from the Shenzhen Stock Exchange [5] - The appointed senior management members meet the qualifications required by the Company Law and have no disqualifying conditions [5] Group 4: Departures of Board Members - Yang Changsheng has stepped down from his position as an independent director and related committee roles, with no shares held in the company [6] - Three supervisors, Li Xian, Qin Ziyin, and Liu Tingting, have also left their positions, with no shares held and no unfulfilled commitments [6]